According to IMARC Group latest report titled “Parenteral Nutrition Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, offers a comprehensive analysis of the industry, which comprises insights on parenteral nutrition market trends. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The global parenteral nutrition market reached a value of US$ 6.3 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 9.3 Billion by 2027, exhibiting a CAGR of 6.77% during 2022-2027.
Parenteral nutrition (PN) refers to the process of feeding nutritional products, such as proteins, carbohydrates, fats, minerals, and vitamins, to individuals who are unable to intake the required nutrition orally. It involves sterilized liquid natural formula that is given to the patient directly through the veins with the help of an intravenous tube or administered peripherally or centrally through the superior vena cava. The composition of the PN solution is carefully balanced depending on the specific nutritional requirement of the patient. It aids in preventing malnutrition and maintaining energy, hydration, and strength levels among individuals. As a result, it is widely used to treat patients who are suffering from cancer, Crohn’s disease, short bowel syndrome, ischemic bowel disease, and abnormal bowel function.
Get a Free Sample Copy of this Report: https://www.imarcgroup.com/parenteral-nutrition-market/requestsample
Market Trends:
The increasing prevalence of chronic diseases among the masses is driving the global market. Along with this, the rising number of premature births and the scarcity of essential nutrients in premature infants and newborns are contributing to the demand across the globe. Moreover, continuous improvements in the PN method, such as lipid emulsions optimizations and utilization of indirect calorimetry, are providing a boost to the market. In line with this, the development of new drugs by key players and approval of novel parenteral nutrition components are acting as other growth-inducing factors. Furthermore, the growing initiatives by governments to promote nutritional awareness among the masses are impacting the market favorably. Other factors, including continuous improvements in healthcare infrastructure, and the increasing frequency of malnutrition among children, are also influencing the market.
View Full Report with TOC & List of Figure: https://www.imarcgroup.com/parenteral-nutrition-market
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Parenteral Nutrition Market Segmentation:
Our report has categorized the market based on region, nutrient type and end use.
Breakup by Nutrient Type:
Breakup by End User:
Breakup by Region:
Key highlights of the report:
Note: We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800